ScholarLens Back to search
2006•Journal of Clinical Medicine in PracticeRequires access

CLINICAL STUDY OF TREATING SEVERE ASTHMA WITH MONTELUKAST ANDBUDESONIDE

Yuying Shen

Open publisher page 0 citations

Abstract

Objective To study the clinical efficacy of montelukast associated with budesonide on severe asthma patients.Methods According to the inclusion and exclusion criteria,30 severe asthma patients were involved in the present trial,and received six weeks′treatment.The clinical efficacy of the combined therapy was observed.Results There was significant amelioration concerning the peak expiratory flow(PEF),the puff number of the salbutamol,and the score of the asthma symptom of the day and night after six weeks′treatment(P0.01).Conclusion Montelukast associated with budesonide can be used to treat severe asthma effectively.

About this research paper

What this paper is about

Objective To study the clinical efficacy of montelukast associated with budesonide on severe asthma patients.Methods According to the inclusion and exclusion criteria,30 severe asthma patients were involved in the present trial,and received six weeks′treatment.The clinical efficacy of the combined therapy was observed.Results There was significant amelioration concerning the peak expiratory flow(PEF),the puff number of the salbutamol,and the score of the asthma symptom of the day and night after six weeks′treatment(P0.01).Conclusion Montelukast associated with budesonide can be used to treat severe asthma effectively.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the clinical efficacy of montelukast associated with budesonide on severe asthma patients.Methods According to the inclusion and exclusion criteria,30 severe asthma patients were involved in the present trial,and received six weeks′treatment.The clinical efficacy of the combined therapy was observed.Results There was significant amelioration concerning the peak expiratory flow(PEF),the puff number of the salbutamol,and the score of the asthma symptom of the day and night after six weeks′treatment(P0.01).Conclusion Montelukast associated with budesonide can be used to treat severe asthma effectively.

Key concepts: Medicine, Montelukast, Budesonide, Salbutamol, Asthma, Clinical trial, Inclusion and exclusion criteria, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
CLINICAL STUDY OF TREATING SEVERE ASTHMA WITH MONTELUKAST ANDBUDESONIDE — Research Paper | ScholarLens